Literature DB >> 17637

Interactions of C-reactive protein with the first component of human complement.

D R Claus, J Siegel, K Petras, A P Osmand, H Gewurz.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 17637

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


× No keyword cloud information.
  36 in total

1.  Surface epithelium related activation of complement differs in Crohn's disease and ulcerative colitis.

Authors:  T S Halstensen; T E Mollnes; P Garred; O Fausa; P Brandtzaeg
Journal:  Gut       Date:  1992-07       Impact factor: 23.059

Review 2.  Immunoserology of infectious diseases.

Authors:  K James
Journal:  Clin Microbiol Rev       Date:  1990-04       Impact factor: 26.132

3.  C-reactive protein-mediated complement activation in polymyalgia rheumatica and other systemic inflammatory diseases.

Authors:  P Vaith; G M Hänsch; H H Peter
Journal:  Rheumatol Int       Date:  1988       Impact factor: 2.631

4.  Suppression of mouse complement activity by contaminants of technical grade pentachlorophenol.

Authors:  K L White; A C Anderson
Journal:  Agents Actions       Date:  1985-07

Review 5.  The protective function of human C-reactive protein in mouse models of Streptococcus pneumoniae infection.

Authors:  Alok Agrawal; Madathilparambil V Suresh; Sanjay K Singh; Donald A Ferguson
Journal:  Endocr Metab Immune Disord Drug Targets       Date:  2008-12       Impact factor: 2.895

6.  A 28,000-dalton protein of normal mouse serum binds specifically to the inner core region of bacterial lipopolysaccharide.

Authors:  L Brade; H Brade
Journal:  Infect Immun       Date:  1985-12       Impact factor: 3.441

7.  Defined chemically cross-linked oligomers of human C-reactive protein: characterization and reactivity with the complement system.

Authors:  H Jiang; T F Lint; H Gewurz
Journal:  Immunology       Date:  1991-12       Impact factor: 7.397

8.  Activation of platelets by modified C-reactive protein.

Authors:  B A Fiedel; R M Simpson; H Gewurz
Journal:  Immunology       Date:  1982-03       Impact factor: 7.397

9.  Binding of C-reactive protein to modified low-density-lipoprotein particles: identification of cholesterol as a novel ligand for C-reactive protein.

Authors:  Sanna Taskinen; Petri T Kovanen; Hanna Jarva; Seppo Meri; Markku O Pentikäinen
Journal:  Biochem J       Date:  2002-10-15       Impact factor: 3.857

10.  Studies on circulating soluble immune complexes of the liver disease. 6. Comparative studies of 125I-pRF inhibition assay, 125I-Clq inhibition assay and 125I-Clq binding assay.

Authors:  J Narumoto
Journal:  Gastroenterol Jpn       Date:  1981
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.